Surgeon General Blames Lack of Marijuana Research on Schedule 1 Status

At a national summit on police efforts to address the United States’ opioid epidemic, U.S. Surgeon General Jerome Adams spoke about the need for further scientific and medical research on cannabis. In response to a question about the U.S. Controlled Substances Act (CSA), Adams called for a review of the way the government schedules different medications, including marijuana. The CSA lists cannabis as a Schedule I substance, a classification reserved for drugs deemed the most dangerous, with no accepted medical use and high abuse potential. The extraordinary difficulty and cost scientists and doctors face if they try to study cannabis is a major consequence of that classification. In the U.S., no drug is both as common yet as under-researched as marijuana. And Surgeon General Adams blames the lack of research on the plant’s Schedule I status.

U.S. Surgeon General Renews Support for Rescheduling Medical Cannabis

Last Thursday’s statements at the Police Assisted Addiction Recovery Initiative conference in Massachusetts weren’t the first time Surgeon General Jerome Adams has spoken favorably about reclassifying medical cannabis. In a public speech last December at the National Black Caucus of State Legislators’ annual conference, Adams said he felt medical marijuana “should be like any other

Read More Here…

Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *